A survey of the availability in Canadian pharmacy chains of over-the-counter natural health products for menopause symptoms

BMC Complementary and Alternative Medicine

Beate C Sydora²  Nese Yuksel¹  Sue Ross²  Jennifer Croden² 

[1] Faculty of Pharmacy and Pharmaceutical Sciences, 3-171 Edmonton Clinic Health Academy, 11405 – 87 Avenue NW, Edmonton T6G 1C9, AB, Canada;Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, University of Alberta, 5S131 Lois Hole Hospital for Women, Robbins Pavilion, Royal Alexandra Hospital, 10240 Kingsway Avenue NW, Edmonton T5H 3 V9, AB, Canada

关键词: Women’s choice;    Menopause symptoms;    Menopause;    Natural health products;    Over-the counter products;   

Others  :  1178847
DOI  :  10.1186/s12906-015-0608-5

 received in 2014-11-21, accepted in 2015-03-12,  发布年份 2015

【 摘 要 】

Background

Menopause is a natural phase in a woman’s aging process, characterized by the cessation of menstruation. Women who are going through the menopause transition can experience physiological symptoms that significantly impact their quality of life. Concern about adverse effects of traditional hormone therapy often leads women to purchase over-the-counter (OTC) natural health products (NHPs). The goal of this study was toinvestigate the range of OTC NHPs for menopause available to Canadian women, and the packaging information they can access to make self-management decisions.

Methods

Edmonton stores belonging to each of nine Canadian pharmacy chains were visited to identify NHPs marketed for the relief of menopausal symptoms. Details were extracted from the packaging: a) product name and manufacturer, b) Health Canada license number, c) medically active ingredients, d) claims of efficacy, e) contra-indications and warnings, and f) daily cost. Data were entered and analyzed using Microsoft Excel.

Results

We identified 20 OTC NHP menopausal products, 19 of which had Health Canada license numbers. Twenty-eight medically active ingredients were identified, with the most common being black cohosh (in 14 products) and soy isoflavones (n = 7), chaste tree (n = 5), and dong quai (n = 3). Most products claimed they would relieve vasomotor symptoms, including hot flashes (n = 14) and night sweats (n = 10). Each product had a labeled contraindication for at least one specific condition. Costs per recommended daily dose ranged from $0.07 to a maximum of $2.50 (CAD$).

Conclusion

Natural health products for menopausal symptoms are easily available to Canadian women. The lack of clear evidence of product efficacy makes the need for easily accessible, balanced information on this topic important for women to make well informed choices.

【 授权许可】

   
2015 Croden et al.; licensee BioMed Central.

【 参考文献 】

• [1]Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review. Health Qual Life Outcomes. 2005; 3:47. BioMed Central Full Text
• [2]Woods NF, Mitchell ES. Symptoms during the perimenopause: Prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005; 2005(118):14-24.
• [3]McNagny SE. Prescribing hormone replacement therapy for menopausal symptoms. Ann Intern Med. 1999; 131:605-616.
• [4]Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Ann Rev Pub Health. 1998; 19:55-72.
• [5]Stuenkel CA, Gass ML, Manson JE, Lobo RA, Pal L, Rebar RW et al.. A decade after the Women’s Health Initiative - the experts do agree. Menopause. 2012; 19:846-847.
• [6]Position statement: estrogen and progestogen use in postmenopausal women. Menopause. 2008; 15:584-603.
• [7]Légaré F, Stacey D, Dodin S, O'Connor A, Richer M, Griffiths F et al.. Women’s decision making about the use of natural health products at menopause: a needs assessment and patient decision aid. J Altern Complement Med. 2007; 13:741-49.
• [8]Lunny CA, Fraser SN. The use of complementary and alternative medicines among a sample of Canadian menopausal-aged women. J Midwifery Womens Health. 2010; 55:335-343.
• [9]Wathen CN. Alternatives to hormone replacement therapy: a multi-method study of women’s experiences. Complement Ther Med. 2006; 14:185-192.
• [10]Health Canada. About Natural Health Product Regulation in Canada. [http://www.hc-sc.gc.ca/dhp-mps/prodnatur/about-apropos/index-eng.php]
• [11]Smith A, Jogalekar S, Gibson A. Regulation of natural health products in Canada. J Ethnopharmacol 2014, pii: S0378-8741 (14)00485-1. doi:10.1016/j.jep.2014.06.037. [Epub ahead of print]
• [12]Kelley KW, Carroll DG. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women. J Am Pharm Assoc. 2003; 50:e106-15.
• [13]Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Syst Rev. 2012; 9:CD007244.
• [14]Teschke R, Bahre R, Genthner A, Fuchs J, Schmidt-Taenzer W, Wolff A. Suspected black cohosh hepatotoxicity–challenges and pitfalls of causality assessment. Maturitas. 2009; 63(4):302-14.
• [15]Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database of Syst Rev. 2013; 12: Article ID CD001395
• [16]Chen MN, Lin CC, Liu C. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric. 2014; 29:1-21.
• [17]Laakmann E, Grajecki D, Doege K, zu Eulenburg C, Buhling KJ. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review. Gynecol Endocrinol. 2012; 28:703-709.
• [18]Health Canada, Site Licensing. [http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-site-exploit/index-eng.php] (accessed 23 February 2015)
• [19]Health Canada, Natural Health Products Compliance and Enforcement Policy. [http://www.hc-sc.gc.ca/dhp-mps/compli-conform/info-prod/prodnatur/complian-conform-pol-eng.php] (accessed 9 February 2015)
• [20]Boon HS, Kachan N. Natural health product labels: is more information always better? Patient Educ Couns. 2007; 68:193-199.
• [21]Braun LA, Tiralongo E, Wilkinson JM, Spitzer O, Bailey M, Poole S et al.. Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. BMC Complement Altern Med. 2010; 10:38. BioMed Central Full Text
• [22]Ismail R, Taylor-Swanson L, Thomas A, Schnall JG, Cray L, Mitchell ES et al.. Effect of herbal preparations on symptom clustering during the menopausal transition. Climacteric. 2015; 18:11-28.
• [23]Shifren JL, Gass ML. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014; 21(10):1038-62.
• [24]Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas. 1995; 21:189-195.
• [25]Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric. 1999; 2:85-92.
• [26]Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA. 2003; 290:207-214.
• [27]Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G et al.. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause. 2009; 16:1156-66.
• [28]Auerbach L, Rakus J, Bauer C, Gerner C, Ullmann R, Wimmer H et al.. Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial. Menopause. 2012; 19:426-432.
• [29]Health Canada, Licensed Natural Health Product Database. [http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lnhpd-bdpsnh-eng.php] (accessed 29 October 2014)
• [30]Gokhale L, Sturdee DW, Parsons AD. The use of food supplements among women attending menopause clinics in the West Midlands. Journal of the British Menopause Society. 2003; 9(1):32-5.
• [31]Gollschewski S, Anderson D, Skerman H, Lyons-Wall P. The use of complementary and alternative medications by menopausal women in South East Queensland. Womens Health Issues. 2004; 14(5):165-71.
• [32]Cardini F, Lesi G, Lombardo F, van der Sluijs C. The use of Complementary and Alternative Medicine by women experiencing menopausal symptoms in Bologna. BMC Womens Health. 2010; 10:7. BioMed Central Full Text
• [33]Koç Z, Saglam Z, Topatan S. Determination of the use of complementary and alternative medicine by women in the climacteric period in the Turkish city of Samsun. Contemp Nurse. 2013; 45(2):197-209.
• [34]Carpenter JS, Studts JL, Byrne MM. A systematic review of menopausal symptom management decision aid trials. Maturitas. 2011; 69:11-21.
• [35]Légaré F, Dodin S, Stacey D, Leblanc A, Tapp S. Patient decision aid on natural health products for menopausal symptoms: randomized controlled trial. Menopause Int. 2008; 14:105-110.
• [36]Menard P, Stacey D, Légare F, Woodend K. Evaluation of a natural health product decision aid: a tool for middle aged women considering menopausal symptom relief. Maturitas. 2010; 65:366-371.
• [37]Gratus C, Wilson S, Greenfield SM, Damery SL, Warmington SA, Grieve R et al.. The use of herbal medicines by people with cancer: a qualitative study. BMC Complement Altern Med. 2009; 14:9-14.
• [38]Vohra S, Cvijovic K, Boon H, Foster BC, Jaeger W, LeGatt D et al.. Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLoS One. 2012; 7(9):e45196.
• [39]Low Dog T, Marles R, Mahady G, Gardiner P, Ko R, Barnes J et al.. Assessing safety of herbal products for menopausal complaints: An international perspective. Maturitas. 2010; 66:355-362.